Your browser doesn't support javascript.
loading
Adaptive preconditioning in neurological diseases - therapeutic insights from proteostatic perturbations.
Mollereau, B; Rzechorzek, N M; Roussel, B D; Sedru, M; Van den Brink, D M; Bailly-Maitre, B; Palladino, F; Medinas, D B; Domingos, P M; Hunot, S; Chandran, S; Birman, S; Baron, T; Vivien, D; Duarte, C B; Ryoo, H D; Steller, H; Urano, F; Chevet, E; Kroemer, G; Ciechanover, A; Calabrese, E J; Kaufman, R J; Hetz, C.
Affiliation
  • Mollereau B; Univ Lyon, ENS de Lyon, Univ Claude Bernard, CNRS UMR5239, INSERM U1210, Laboratory of Biology and Modelling of the Cell, F-69007, Lyon, France. Electronic address: bertrand.mollereau@ens-lyon.fr.
  • Rzechorzek NM; Centre for Clinical Brain Sciences, Chancellor's Building, University of Edinburgh, Edinburgh EH16 4SB, United Kingdom; Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush Campus, Roslin, Midlothian EH25 9RG, United Kingdom.
  • Roussel BD; Inserm, UMR-S U919 Serine Proteases and Pathophysiology of the Neurovascular Unit, 14000 Caen, France.
  • Sedru M; Univ Lyon, ENS de Lyon, Univ Claude Bernard, CNRS UMR5239, INSERM U1210, Laboratory of Biology and Modelling of the Cell, F-69007, Lyon, France.
  • Van den Brink DM; Univ Lyon, ENS de Lyon, Univ Claude Bernard, CNRS UMR5239, INSERM U1210, Laboratory of Biology and Modelling of the Cell, F-69007, Lyon, France.
  • Bailly-Maitre B; INSERM U1065, C3M, Team 8 (Hepatic Complications in Obesity), Nice, France.
  • Palladino F; Univ Lyon, ENS de Lyon, Univ Claude Bernard, CNRS UMR5239, INSERM U1210, Laboratory of Biology and Modelling of the Cell, F-69007, Lyon, France.
  • Medinas DB; Biomedical Neuroscience Institute, Faculty of Medicine, University of Chile, Santiago, Chile; Center for Molecular Studies of the Cell, Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago, Chile; Center for Geroscience, Brain Health and Metaboli
  • Domingos PM; ITQB-UNL, Av. da Republica, EAN, 2780-157 Oeiras, Portugal.
  • Hunot S; Inserm, U 1127, F-75013 Paris, France; CNRS, UMR 7225, F-75013 Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013 Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, F-75013 Paris, France.
  • Chandran S; Centre for Clinical Brain Sciences, Chancellor's Building, University of Edinburgh, Edinburgh EH16 4SB, United Kingdom.
  • Birman S; Genes Circuits Rhythms and Neuropathology, Brain Plasticity Unit, CNRS UMR 8249, ESPCI ParisTech, PSL Research University, 75005 Paris, France.
  • Baron T; ANSES, French Agency for Food, Environmental and Occupational Health & Safety, Neurodegenerative Diseases Unit, 31, avenue Tony Garnier, 69364 Lyon Cedex 07, France.
  • Vivien D; Inserm, UMR-S U919 Serine Proteases and Pathophysiology of the Neurovascular Unit, 14000 Caen, France.
  • Duarte CB; CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Faculty of Medicine, Rua Larga, and Department of Life Sciences, University of Coimbra, 3004-504 Coimbra, Portugal.
  • Ryoo HD; Department of Cell Biology, New York University School of Medicine, New York, NY, USA.
  • Steller H; Howard Medical Institute, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA.
  • Urano F; Washington University School of Medicine, Department of Internal Medicine, St. Louis, MO 63110 USA.
  • Chevet E; Inserm ERL440 "Oncogenesis, Stress, Signaling", Université de Rennes 1, Rennes, France; Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.
  • Kroemer G; Equipe 11 labellisée par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Cell Biology and Metabolomics platforms, Gustave Roussy Comprehensive Cancer Center, Villejuif, France; INSERM, U1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France;
  • Ciechanover A; The Polak Cancer and Vascular Biology Research Center, The Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa 30196, Israel.
  • Calabrese EJ; Department of Environmental Health Sciences, University of Massachusetts, Morrill I, N344, Amherst, MA 01003, USA.
  • Kaufman RJ; Degenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, 10901 N. Torrey Pines Rd., La Jolla, CA 92037, USA.
  • Hetz C; Biomedical Neuroscience Institute, Faculty of Medicine, University of Chile, Santiago, Chile; Center for Molecular Studies of the Cell, Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago, Chile; Center for Geroscience, Brain Health and Metaboli
Brain Res ; 1648(Pt B): 603-616, 2016 10 01.
Article in En | MEDLINE | ID: mdl-26923166
ABSTRACT
In neurological disorders, both acute and chronic neural stress can disrupt cellular proteostasis, resulting in the generation of pathological protein. However in most cases, neurons adapt to these proteostatic perturbations by activating a range of cellular protective and repair responses, thus maintaining cell function. These interconnected adaptive mechanisms comprise a 'proteostasis network' and include the unfolded protein response, the ubiquitin proteasome system and autophagy. Interestingly, several recent studies have shown that these adaptive responses can be stimulated by preconditioning treatments, which confer resistance to a subsequent toxic challenge - the phenomenon known as hormesis. In this review we discuss the impact of adaptive stress responses stimulated in diverse human neuropathologies including Parkinson׳s disease, Wolfram syndrome, brain ischemia, and brain cancer. Further, we examine how these responses and the molecular pathways they recruit might be exploited for therapeutic gain. This article is part of a Special Issue entitled SIER stress.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Autophagy / Proteostasis Deficiencies / Unfolded Protein Response / Nervous System Diseases Limits: Animals / Humans Language: En Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Autophagy / Proteostasis Deficiencies / Unfolded Protein Response / Nervous System Diseases Limits: Animals / Humans Language: En Year: 2016 Type: Article